We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Robotic 3D Ultrasound System Improves Accuracy of Liver Cancer Treatment

By HospiMedica International staff writers
Posted on 27 Jan 2023

Liver cancer is the fourth-leading cause of cancer death in the world. More...

Surgery is one treatment option for liver cancer, although thermal ablation which uses heat to destroy the cancerous tumor has less complications and a quicker recovery time. It can also be performed on patients who are not fit for surgery due to some reasons. However, thermal ablation requires precise needle placement to treat the cancer without damaging the vital organs and blood vessels surrounding it. Now, a new system that uses ultrasound to construct 3D-images could increase the accuracy of thermal ablation for treating liver cancer.

Generally, ultrasound or CT (computerized tomography) imaging is used to guide needle placement, although both are limited. Although ultrasound is widely available and can be performed in real-time, it delivers only 2D images. On the other hand, a CT scan generates 3D images, but not in real time and is a lengthy process. In order to create 3D ultrasound images, the new system uses a robotic cradle to move a standard ultrasound probe, collecting images and stacking them like puzzle pieces. In a simulated study, researchers at Western University (Ontario, Canada) and Lawson Health Research Institute (Ontario, Canada) used data from 14 patient cases to analyze the technology’s accuracy. They found that with standard imaging, there was complete tumor ablation in 64.3% of cases, while the new system offered complete coverage for 92.9% of cases (13 out of 14 cases). They found that in the one remaining case, the patient could benefit from increased ablation time or intensity. If the robotic ultrasound system proves to be effective, then its portability could enable more widespread use of 3D ultrasound imaging, such as in smaller health care centers. Additionally, it could also reduce imaging wait times by eliminating the need for CT scans.

“We developed a new 3D ultrasound method that shows promise in analyzing whether the complete liver tumor will be ablated by the procedure,” explained Aaron Fenster, professor at Schulich Medicine & Dentistry and scientist at Robarts Research Institute. “And we’re now using the same system to guide the needle directly into the centre of the tumor.”

Related Links:
Western University
Lawson Health Research Institute 


Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Desk Aneroid Sphyg
Diagnostix 750D+
Patient Preoperative Skin Preparation
BD ChloraPrep
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Artificial intelligence (AI) standalone performance and reader performance with versus without AI assistance. (A) Receiver operating characteristics (ROC) curve for AI standalone performance in the US dataset (AUC 0.899, 95% CI 0.858 to 0.939). (B) ROC curve for AI standalone performance in the Korean dataset (AUC 0.963, 95% CI 0.946 to 0.975). (C) Pooled reader ROC without (AUC 0.718) versus with (AUC 0.852) AI assistance in the Korean dataset; P<0.001. AUC, area under the receiver operating characteristics curve. (Leonard Sunwoo et al., Journal of NeuroInterventional Surgery (2026). DOI: 10.1136/jnis-2026-025339)

AI Improves Non-Contrast CT Interpretation for Time-Sensitive Stroke Assessment

Acute ischemic stroke occurs when a blood vessel in the brain becomes blocked, requiring rapid diagnosis to enable timely reperfusion therapy. Emergency departments often use computed tomography angiography... Read more

Critical Care

view channel
Image Credit: Adobe Stock

Noninvasive Imaging Approach Aims to Detect Basal Cell Carcinoma Before It Becomes Visible

Basal cell carcinoma is the most common form of skin cancer and can damage nearby structures such as the nose or eyes when it develops on the face. Diagnosis typically depends on visible skin changes,... Read more

Surgical Techniques

view channel
Image: Associate Professor Menglin Chen studies how the light-sensitive nanoparticles affect living cells. The screen shows calcium being released inside a cell after nanoparticles taken up by the cell are exposed to blue light. Calcium plays an important role in cellular signaling, and the experiment helps the researchers understand how the nanoparticles can translate light into biological activity. (Photo courtesy of Aarhus University, Johanne Holm Jensen)

Light-Activated Nanoparticles May Offer New Approach to Retinal Prostheses

Retinitis pigmentosa is a degenerative retinal disorder in which photoreceptors progressively die, reducing visual signals to the brain while leaving surviving inner retinal circuits underused.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.